Abstract

ObjectiveWe aimed to assess the impact of surgical intervention on outcome in patients diagnosed with demyelinating disorders and cervical degenerative disease warranting surgical intervention.MethodsThe records of patients with a diagnosis of a demyelinating disorder of the central nervous system who underwent cervical spine surgery at a single institution from 2016 to 2020 were reviewed. Demyelinating disease included multiple sclerosis (MS), neuromyelitis optica, and transverse myelitis (TM). The dates of initial spine symptom onset, recognition of spinal pathology by the primary provider, referral to spine surgery, and spine surgery procedures were collected. Hospital length of stay (LOS) and postoperative outcomes and complications were recorded.ResultsA total of 19 patients with a diagnosis of demyelinating disorders underwent cervical spine surgery at our institution. Seventeen patients had MS. The average time interval between a documented diagnosis of myelopathy or radiculopathy and referral to the Spine clinic was 67.95 months (M=40, SD=64.87). Twelve patients had imaging studies depicting degenerative spine disease that would warrant surgical intervention at the time of examination by their primary physician. The average delay for referral to the Spine clinic for these patients was 16.5 months (M=5; SD=25.36). More than 89% of patients experienced significant neurologic improvement postoperatively.ConclusionsThere is a delay in the recognition of cervical spine disease amenable to a surgical resolution in patients with demyelinating disorders. Surgical treatment can lead to significant clinical improvement in this patient population even if delayed, and likely carries similar risk to that of the general population.

Highlights

  • Demyelinating disorders consist of a wide spectrum of diseases resulting in the destruction of neuronal myelin sheath

  • There is a delay in the recognition of cervical spine disease amenable to a surgical resolution in patients with demyelinating disorders

  • Surgical treatment can lead to significant clinical improvement in this patient population even if delayed, and likely carries similar risk to that of the general population

Read more

Summary

Introduction

Demyelinating disorders consist of a wide spectrum of diseases resulting in the destruction of neuronal myelin sheath. The clinical presentation of MS is highly variable, but symptoms often include sensory changes, motor deficits, gait imbalance, and bowel or bladder dysfunction [2], many of which are common in patients with cervical spondylotic myelopathy or radiculopathy. Prior studies have demonstrated that patients with DD and CS may benefit from surgical decompression [3,4,5,6,7]. It is still unclear how this combination delays the appropriate diagnosis and treatment of surgical spine disease, and whether surgical treatment can still clinically benefit patients despite this delay

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call